Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug–controlled study
Michael E. Weinblatt, Michael H. Schiff, Eric M. Ruderman, Clifton O. Bingham III, Juan Li, James Louie, Daniel E. FurstТом:
58
Рік:
2008
Мова:
english
Сторінки:
10
DOI:
10.1002/art.23493
Файл:
PDF, 203 KB
english, 2008